Rhonda Rosengren
#163,308
Most Influential Person Now
New Zealand toxicology researcher
Rhonda Rosengren's AcademicInfluence.com Rankings
Rhonda Rosengrenmedical Degrees
Medical
#3325
World Rank
#3792
Historical Rank
Toxicology
#48
World Rank
#52
Historical Rank
Download Badge
Medical
Rhonda Rosengren's Degrees
- Bachelors Toxicology University of Auckland
- Masters Toxicology University of New Zealand
- PhD Toxicology Massey University
Why Is Rhonda Rosengren Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rhonda J Rosengren is a New Zealand toxicology academic, and as of 2019 is a full professor at the University of Otago. Academic career After at Texas A&M University, Rosengren moved to the University of Otago, rising to full professor.
Rhonda Rosengren's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy (2019) (177)
- Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs (2012) (149)
- Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. (2006) (148)
- Sex-specific differences in CYP450 isoforms in humans (2008) (146)
- The combination of epigallocatechin gallate and curcumin suppresses ERα‐breast cancer cell growth in vitro and in vivo (2007) (129)
- Cannabinoids in the treatment of cancer. (2009) (125)
- Tumor-associated macrophages: role in cancer development and therapeutic implications (2019) (124)
- Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells (2004) (98)
- 2,2′,4,4′,5,5′-Hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL6J mice (1989) (92)
- Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. (2010) (91)
- Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. (2002) (81)
- A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate (2008) (77)
- Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines (2011) (62)
- Critical appraisal of the potential use of cannabinoids in cancer management (2013) (61)
- St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. (2002) (59)
- Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss-Webster mouse. (2003) (57)
- Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse. (2006) (41)
- Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer (2020) (40)
- Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. (1995) (39)
- Sex- and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in the mouse. (2006) (38)
- Retinol potentiates acetaminophen-induced hepatotoxicity in the mouse: mechanistic studies. (2001) (36)
- (−)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia (2005) (34)
- Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers (2013) (32)
- The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells. (2008) (32)
- Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance. (2015) (29)
- Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells (2009) (26)
- Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonists: characterization of 6-[125I]methyl-8-iodo-1,3-dichlorodibenzofuran-Ah receptor complexes. (1991) (25)
- Mechanism of benzo[a]pyrene-induced Cyp1a-1 gene expression in mouse Hepa 1c1c7 cells: role of the nuclear 6 s and 4 s proteins. (1992) (25)
- The effect of retinol on hepatic and renal drug-metabolising enzymes. (2001) (25)
- Structure-dependent induction of aryl hydrocarbon hydroxylase activity in C57BL/6 mice by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related congeners: mechanistic studies. (1990) (25)
- Short term treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse. (2002) (23)
- Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer (2013) (23)
- In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells. (2010) (22)
- 2,2',4,4',5,5'-hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6J mice. (1989) (22)
- RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells. (2012) (20)
- Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells. (2007) (20)
- Vitamin A modulation of xenobiotic-induced hepatotoxicity in rodents. (1994) (19)
- RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models. (2012) (19)
- Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer. (2017) (18)
- Methylphenidate inhibits cytochrome P450 in the Swiss Webster mouse (2002) (18)
- Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expression. (2013) (18)
- Role of cytochrome P4502E1 in retinol's attenuation of carbon tetrachloride-induced hepatotoxicity in the Swiss Webster mouse. (1999) (18)
- Catechins and the treatment of breast cancer: possible utility and mechanistic targets. (2003) (17)
- A Novel Role for Raloxifene Nanomicelles in Management of Castrate Resistant Prostate Cancer (2014) (16)
- Immobilised apple peel bead biosorbent for the simultaneous removal of heavy metals from cocktail solution (2019) (14)
- A Multitargeted Approach in the Discovery of an Organorhodium Anticancer Agent Based On Vorinostat as a Potent Histone Deacetylase Inhibitor. (2020) (14)
- Deer velvet supplementation decreases the grade and metastasis of azoxymethane-induced colon cancer in the male rat. (2010) (13)
- A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer (2016) (13)
- Acetaminophen elicits anti-estrogenic but not estrogenic responses in the immature mouse. (2001) (13)
- The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer. (2017) (13)
- The Rationale for Repurposing Sildenafil for Lung Cancer Treatment. (2017) (13)
- Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer (2016) (12)
- Characterization of the aryl hydrocarbon receptor in the human C-4II cervical squamous carcinoma cell line. (1992) (11)
- Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells (2011) (10)
- A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines. (2016) (10)
- Mechanisms of suppression of cell growth by dual inhibition of ALK and MEK in ALK-positive non-small cell lung cancer (2019) (10)
- The Interactions between Retinol and Five Different Hepatotoxicants in the Swiss Webster Mouse (1995) (10)
- St . John ’ s Wort Extract Induces CYP 3 A and CYP 2 E 1 in the Swiss Webster Mouse (2002) (9)
- Promise of gold nanomaterials as a lung cancer theranostic agent: a systematic review (2021) (9)
- Simultaneous removal of heavy metals from drinking water by banana, orange and potato peel beads: a study of biosorption kinetics (2021) (9)
- The interactions between retinol and five different hepatotoxicants in the Swiss Webster mouse. (1995) (8)
- The Effect of Metformin in EML4-ALK+ Lung Cancer alone and in Combination with Crizotinib in Cell and Rodent Models. (2020) (8)
- Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells (2017) (8)
- Cytotoxicity of curcumin derivatives in ALK positive non-small cell lung cancer. (2019) (7)
- Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer (2017) (7)
- Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells (2021) (7)
- Hepatic cytochrome P450 activity and pollutant concentrations in paradise shelducks and southern black-backed gulls in the South Island of New Zealand (2008) (6)
- Cucumber peel bead biosorbent for multi-ion decontamination of drinking water collected from a mine region in New Zealand (2019) (6)
- Induction of in vitro EROD activity and in vivo caffeine metabolism in two species of New Zealand birds. (2008) (6)
- Six fruit and vegetable peel beads for the simultaneous removal of heavy metals by biosorption (2020) (6)
- Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer (2021) (5)
- Kinetics of the association of several tritiated polychlorinated dibenzo-p-dioxin and dibenzofuran congeners with hepatic cytosolic Ah receptor from the Wistar rat. (1992) (5)
- High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes (2021) (5)
- RL 71 , a second-generation curcumin analog , induces apoptosis and downregulates Akt in ER-negative breast cancer cells (2012) (5)
- A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor (2020) (5)
- Experimental Therapeutics for the Treatment of Triple Negative Breast Cancer (2011) (4)
- The Synthesis of (±)-Oxyisocyclointegrin (2019) (4)
- Does the mouse tail vein injection method provide a good model of lung cancer? (2019) (3)
- Molecular Pathways, Screening and Follow-up of Colorectal Carcinogenesis: An Overview (2020) (2)
- A multivariate statistical analysis of the effects of styrene maleic acid encapsulated RL71 in a xenograft model of triple negative breast cancer (2019) (2)
- Using natural compounds to target KRAS mutated non-small cell lung cancer. (2021) (2)
- 5085 POSTER New Curcumin Analogue RL-66 Has Promising Anti-breast Cancer and Antiangiogenic Activity (2011) (2)
- Renal PGE2 production in the human and rat following phenacetin, acetaminophen and p-aminophenol. (2002) (2)
- Ontogeny of hepatic microsomal 3-hydroxylation of quinine in Adélie Penguins. (2004) (2)
- Raloxifene: Promises and Challenges as a Drug Treatment for Castrate Resistant Prostate Cancer (2017) (2)
- Does Crizotinib Auto-Inhibit CYP3A in vivo? (2020) (2)
- In Vitro Hepatic Assessment of Cineole and Its Derivatives in Common Brushtail Possums (Trichosurus vulpecula) and Rodents (2021) (2)
- Characterisation of AMB-FUBINACA metabolism and CB1-mediated activity of its acid metabolite (2022) (1)
- Is Brca-Associated Protein (Bap1) A New Drug Target to Combat Metastatic Uveal Melanoma? (2018) (1)
- Biosorption of heavy metals from water: mechanism, critical evaluation and translatability of methodology (2022) (1)
- Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK-Positive Lung Cancer (2020) (1)
- Modulation of hepatic drug metabolizing enzymes by the natural polyphenol curcumin (2017) (1)
- Synthesis and Biological Evaluation of (−) and (+)‐Spiroleucettadine and Analogues (2020) (1)
- Key considerations when using the sulforhodamine B assay for screening novel anticancer agents. (2021) (1)
- 1237 POSTER WIN55,212-2 as a Potential Treatment for Estrogen-receptor Negative Breast Cancer (2011) (1)
- Inhibition of MEK alone and in combination with ALK inhibition suppresses tumor growth in a mouse model of ALK positive lung cancer. (2020) (1)
- Characterization of the human Ah receptor (1992) (0)
- Potential mechanisms for the cytotoxicity elicited by the combination of EGCG and raloxifene in MDA-MB-231 cells (2008) (0)
- Kinetics of the association of several tritiated PCDD and PCDF congeners with the cytosolic Ah receptor from the Sprague-Dawley rat (1990) (0)
- Exploring the Mechanism and Suggesting Combination Therapies for HDAC Inhibitors in Androgen Receptor-Null Prostate Cancer Using Multivariate Statistical Analysis and Data Mining Techniques (2022) (0)
- The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism (2023) (0)
- An Organorhodium Anticancer Agent with a Non-conventional Mode of Action Based on a Histone Deacetylase Inhibitor and a Plectin-targeting Agent (2020) (0)
- Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines (2022) (0)
- Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer (2022) (0)
- Abstract 3556: New curcumin analogues are cytotoxic towards estrogen receptor negative human breast cancer cell lines (2010) (0)
- Dietary retinol as a toxic substance. (2003) (0)
- Non-Equilibrium Multi-Ion Biosorption Isotherms for Removal of Heavy Metals from Drinking Water (2021) (0)
- P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer (2018) (0)
- Tumor-associated macrophages: role in cancer development and therapeutic implications (2019) (0)
- Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs (2012) (0)
- Curcumin-derivative RL 71 micelles for the treatment of breast cancer (2013) (0)
- Raloxifene micelles for the treatment of prostate cancer (2013) (0)
- Interactions between EGCG and SERMs in a xenograft model of ERα- breast cancer. (2008) (0)
- Abstract 4669: A combination of raloxifene and gefitinib potentiates the cytotoxicity and induces apoptosis in estrogen receptor negative breast cancer cell lines (2012) (0)
- Characterization of marine-derived halogenated indoles as ligands of the aryl hydrocarbon receptor (2022) (0)
- 901 IMPROVING MOTHER NATURE: ENHANCED ANTICANCER ACTIVITY DEMONSTRATED BY STRUCTURAL VARIANTS OF CURCUMIN (2020) (0)
This paper list is powered by the following services:
Other Resources About Rhonda Rosengren
What Schools Are Affiliated With Rhonda Rosengren?
Rhonda Rosengren is affiliated with the following schools:
